Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess

Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess

Clostridioides (formerly Clostridium) difficile infection is a common and costly healthcare-associated infection. Extraintestinal C. difficile infection is rarely encountered, especially in isolation. We present a unique case of abdominal wall abscess presenting six months following gastrointestinal...

Bibliografske podrobnosti
Main Authors:	Justine Chinnappan, Murtaza Hussain, Dominic Awuah, Ekwevugbe Ogbon, Ghassan Bachuwa, Philip McDonald
Format:	Article
Jezik:	English
Izdano:	SMC MEDIA SRL 2023-02-01
Serija:	European Journal of Case Reports in Internal Medicine
Teme:	extraintestinal cdi abdominal wall abscess persistent c. difficile abscess
Online dostop:	https://www.ejcrim.com/index.php/EJCRIM/article/view/3711

Podobne knjige/članki

Treatment of Extra-Intestinal Clostridioides difficile Abscess following Acute Appendicitis
od: Tulika Chatterjee, et al.
Izdano: (2022-09-01)

Splenic Abscess Caused by Clostridium difficile
od: Chee Yik Chang, et al.
Izdano: (2023-08-01)

Extraintestinal <i>Clostridioides difficile</i> Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature
od: Edit Urbán, et al.
Izdano: (2020-01-01)

Editorial: Clostridioides difficile infection
od: Guido Granata, et al.
Izdano: (2024-02-01)

Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study
od: Danilo Buonsenso, et al.
Izdano: (2022-04-01)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
od: Silvia Vázquez-Cuesta, et al.
Izdano: (2023-04-01)

Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
od: Duolong Zhu, et al.
Izdano: (2018-02-01)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
od: Kristina Rizzardi, et al.
Izdano: (2018-09-01)

Case report: post-salmonellosis abscess positive for Salmonella Oranienburg
od: Brenda M. Castlemain, et al.
Izdano: (2022-04-01)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)
od: Sahil Khanna, et al.
Izdano: (2022-09-01)

Prevalence, antibiogram, phenotypic and genotypic analysis of Clostridioides difficile toxigenic strains from stool samples
od: Mohammed A. Alqasem, et al.
Izdano: (2023-08-01)

Pathogenicity and virulence of Clostridioides difficile
od: Jessica E. Buddle, et al.
Izdano: (2023-12-01)

Recognition, Diagnosis, and Treatment of <i>Clostridioides difficile</i> Enterocolitis Presenting Without Diarrhea: A Literature Review
od: Ezgi Yılmaz, et al.
Izdano: (2025-02-01)

Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020
od: Chinenye M. Okafor, et al.
Izdano: (2023-05-01)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
od: Laura Tijerina-Rodríguez, et al.
Izdano: (2022-02-01)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
od: Ting Gu, et al.
Izdano: (2022-08-01)

Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI)
od: Carolin F. Manthey, et al.
Izdano: (2019-12-01)

Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022
od: Orna Schwartz, et al.
Izdano: (2023-12-01)

Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation
od: Omar Ahmad, et al.
Izdano: (2021-06-01)

Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
od: Pedro Puerta-Alcalde, et al.
Izdano: (2025-04-01)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
od: Teena Chopra, et al.
Izdano: (2023-01-01)

Clostridium difficile Bacteremia as a Rare Presentation of Polymicrobial Pyogenic Liver Abscesses and Its Management Challenges
od: Junghyun Lim, et al.
Izdano: (2023-09-01)

Bezlotoxumab in Patients with a Primary <i>Clostridioides difficile</i> Infection: A Literature Review
od: Guido Granata, et al.
Izdano: (2022-10-01)

Characterization of a Clostridioides difficile outbreak caused by PCR ribotype 046, associated with increased mortality
od: Cecilia Magnusson, et al.
Izdano: (2022-12-01)

Patient Experiences with Clostridioides difficile Infection: Results of a Canada-Wide Survey
od: Vent-Schmidt J, et al.
Izdano: (2020-01-01)

The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity
od: Nicholas A. Lesniak, et al.
Izdano: (2022-08-01)

Fidaxomicin for the Treatment of <i>Clostridioides difficile</i> Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
od: Daniele Roberto Giacobbe, et al.
Izdano: (2022-10-01)

Clostridioides difficile infection in infants: a case report and literature review
od: Zhirong Li, et al.
Izdano: (2023-06-01)

Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008–2015
od: Veronica Zanichelli, et al.
Izdano: (2020-06-01)

Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples
od: Dae Hyeon Cho, et al.
Izdano: (2024-04-01)

ESTRATÉGIAS PARA REDUÇÃO DOS CASOS DE CLOSTRIDIOIDES DIFFICILE NA UNIDADE DE TERAPIA INTENSIVA: ABORDAGEM MULTIFATORIAL
od: Luciana Rodrigues da Silva, et al.
Izdano: (2023-10-01)

Establishment of a gnotobiotic pig model of Clostridioides difficile infection and disease
od: Charlotte Nyblade, et al.
Izdano: (2022-06-01)

Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis
od: Sevliya Öcal Demir, et al.
Izdano: (2021-12-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
od: Ronald G. Hall, et al.
Izdano: (2022-02-01)

Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case–control study
od: Min Hyung Kim, et al.
Izdano: (2022-01-01)

A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models
od: April K. Roberts, et al.
Izdano: (2020-09-01)

Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection
od: Silvia Vázquez-Cuesta, et al.
Izdano: (2023-09-01)

Development and Implementation of Whole Genome Sequencing-Based Typing Schemes for Clostridioides difficile
od: Sandra Janezic, et al.
Izdano: (2019-10-01)

Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
od: Roberto Rosato, et al.
Izdano: (2024-12-01)

Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection
od: Shaohui Wang, et al.
Izdano: (2022-04-01)